|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation - stock options | |||||
| Stock based compensation - common stock | |||||
| Stock-based compensation - stock issued for services | |||||
| Non-cash interest expense | |||||
| Depreciation and amortization | |||||
| Right of use amortization | |||||
| Non-cash operating lease costs | |||||
| Bad debt expense | |||||
| Loss on assets held for sale | |||||
| Change in fair value of derivative liability | |||||
| Gain on extinguishment of convertible notes, net | |||||
| Loss on issuance of convertible notes | |||||
| Other | |||||
| Impairment of intangible assets | |||||
| Impairment of goodwill | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Contract assets | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Lease liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash acquired in acquisitions, net | |||||
| Proceeds from the sale of property and equipment | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from sale of common stock | |||||
| Proceeds from sales of common stock, net of offering costs | |||||
| Proceeds from stock option exercises | |||||
| Proceeds from issuance of Series B Preferred Stock, net of offering costs | |||||
| Proceeds from exercises of warrants | |||||
| Proceeds from loans payable | |||||
| Proceeds from convertible notes payable | |||||
| Proceeds from convertible note payable | |||||
| Proceeds from line of credit | |||||
| Payments on line of credit | |||||
| Payments on loans payable | |||||
| Payments on convertible notes payable | |||||
| Payments of debt issuance costs | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of the period | |||||
| Cash and cash equivalents - end of the period | |||||
| Cash from continuing operations | |||||
| Cash from discontinued operations | |||||
| Supplemental cash flow information: | |||||
| Cash paid for: | |||||
| Interest | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Operating lease assets obtained in exchange for operating lease liabilities | |||||
| Common stock issued as a lending discount | |||||
| Common stock issued in exchange for services | |||||
| SB Cyber | |||||
| Total common stock issued in exchange for services | |||||
| Debt conversion to equity - common stock | |||||
| Debt conversion to equity - Series A Preferred Stock | |||||
| Conversion of Series A Preferred Stock to common stock | |||||
| Conversion of Series B Preferred Stock to common stock | |||||
| Accretion of Series B Preferred Stock to redemption value | |||||
Loading...